Profil
Christopher M.
Murphy is Chief Financial Officer at AnaptysBio, Inc. since 2026.
Formerly, Mr. Murphy was Treasurer, Chief Financial & Business Officer at Third Harmonic Bio, Inc. from 2024 to 2025.
From 2014 to 2020, Mr. Murphy was Group Vice President-Commercial Operations at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020.
Mr. Murphy completed undergraduate studies at the University of Notre Dame.
Aktiva positioner av Christopher Murphy
| Företag | Position | Start |
|---|---|---|
| ANAPTYSBIO, INC. | Finansdirektör/CFO | 2026-05-11 |
Tidigare kända positioner av Christopher Murphy
| Företag | Position | Slut |
|---|---|---|
| THIRD HARMONIC BIO, INC. | Finansdirektör/CFO | 2025-12-01 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Företagsledare/Principal | 2020-05-01 |
Christopher Murphys utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
University of Notre Dame
University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AnaptysBio, Inc.
AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Third Harmonic Bio, Inc.
Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
















